Abiopharma

GT Biopharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates

Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test

Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth

Ecolab Inc. - Ecolab Strengthens Integrated Cooling Program for Data Centers

Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025

Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock

AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth